87 related articles for article (PubMed ID: 207235)
1. Quantitative nuclear-cytoplasmic ratios in human hepatomas.
Gallagher JC
Arch Pathol Lab Med; 1978 Apr; 102(4):189-92. PubMed ID: 207235
[TBL] [Abstract][Full Text] [Related]
2. Ultrastructure of hepatocellular carcinoma in a cirrhotic liver.
Livni N; Behar A; Brautbar N
Isr J Med Sci; 1977 Jun; 13(6):590-9. PubMed ID: 195915
[TBL] [Abstract][Full Text] [Related]
3. Morphological precursors of hepatocellular carcinoma: a morphometrical analysis.
Giannini A; Zampi G; Bartoloni F; Omer S
Hepatogastroenterology; 1987 Jun; 34(3):95-7. PubMed ID: 3038718
[TBL] [Abstract][Full Text] [Related]
4. Quantitative cytologic measurements in hepatomas.
Gallagher JC
Arch Pathol; 1974 Jun; 97(6):392-4. PubMed ID: 4363394
[No Abstract] [Full Text] [Related]
5. Large cell change (liver cell dysplasia) and hepatocellular carcinoma in cirrhosis: matched case-control study, pathological analysis, and pathogenetic hypothesis.
Lee RG; Tsamandas AC; Demetris AJ
Hepatology; 1997 Dec; 26(6):1415-22. PubMed ID: 9397980
[TBL] [Abstract][Full Text] [Related]
6. The expression of c-myc and c-N-ras in human cirrhotic livers, hepatocellular carcinomas and liver tissue surrounding the tumors.
Zhang XK; Huang DP; Qiu DK; Chiu JF
Oncogene; 1990 Jun; 5(6):909-14. PubMed ID: 2163054
[TBL] [Abstract][Full Text] [Related]
7. Hepatocellular nodules in cirrhosis: focus on diagnostic criteria on liver biopsy. A Western experience.
Roncalli M
Liver Transpl; 2004 Feb; 10(2 Suppl 1):S9-15. PubMed ID: 14762832
[TBL] [Abstract][Full Text] [Related]
8. Hyaline cytoplasmic inclusions in human hepatoma. A case report.
Grimelius L; Stenram U; Westman J; Westman-Naeser S
Acta Cytol; 1977; 21(3):469-76. PubMed ID: 196465
[TBL] [Abstract][Full Text] [Related]
9. Detection of micronuclei formation and nuclear anomalies in regenerative nodules of human cirrhotic livers and relationship to hepatocellular carcinoma.
de Almeida TM; Leitão RC; Andrade JD; Beçak W; Carrilho FJ; Sonohara S
Cancer Genet Cytogenet; 2004 Apr; 150(1):16-21. PubMed ID: 15041218
[TBL] [Abstract][Full Text] [Related]
10. [Clinical significance of hyperechogenic focal lesions of the cirrhotic liver].
Giorgio A; Amoroso P; de Stefano G; Fico P; Tarantino L; Lettieri G; Pierri P; Finelli L; Pierri G
Radiol Med; 1988 Mar; 75(3):173-6. PubMed ID: 2451843
[TBL] [Abstract][Full Text] [Related]
11. Nucleolar organizer regions in cirrhosis and hepatocellular carcinoma.
Jain R; Malhotra V; Kumar N; Sarin SK
Trop Gastroenterol; 1998; 19(3):100-1. PubMed ID: 9828706
[TBL] [Abstract][Full Text] [Related]
12. Histological and morphometrical indicators for a biopsy diagnosis of well-differentiated hepatocellular carcinoma.
Nagato Y; Kondo F; Kondo Y; Ebara M; Ohto M
Hepatology; 1991 Sep; 14(3):473-8. PubMed ID: 1651898
[TBL] [Abstract][Full Text] [Related]
13. AgNORs count and DNA ploidy in liver biopsies from patients with schistosomal liver cirrhosis and hepatocellular carcinoma.
Attallah AM; Tabll AA; El-Nashar E; El-Bakry KA; El-Sadany M; Ibrahim T; El-Dosoky I
Clin Biochem; 2009 Nov; 42(16-17):1616-20. PubMed ID: 19682447
[TBL] [Abstract][Full Text] [Related]
14. Identification of c-Yes expression in the nuclei of hepatocellular carcinoma cells: involvement in the early stages of hepatocarcinogenesis.
Nonomura T; Masaki T; Morishita A; Jian G; Uchida N; Himoto T; Izuishi K; Iwama H; Yoshiji H; Watanabe S; Kurokohchi K; Kuriyama S
Int J Oncol; 2007 Jan; 30(1):105-11. PubMed ID: 17143518
[TBL] [Abstract][Full Text] [Related]
15. A case of hepatocellular carcinoma occurring in a cirrhotic liver--laparoscopically confirmed transition from a cirrhotic nodule to a hepatocellular carcinoma at an interval of 10 months.
Iwamura K; Hirayama S; Inaba R; Golebiowski M
Tokai J Exp Clin Med; 1984 Mar; 9(1):69-79. PubMed ID: 6100145
[TBL] [Abstract][Full Text] [Related]
16. [Hepatocellular carcinoma in the non-cirrhotic liver: renewed interest].
Bernard PH; Blanc JF; Le Bail B; de Ledinghen V; Rullier A; Balabaud C; Bioulac-Sage P
Gastroenterol Clin Biol; 1998 Apr; 22(4):371-4. PubMed ID: 9762265
[No Abstract] [Full Text] [Related]
17. HGF, MET, and matrix-related proteases in hepatocellular carcinoma, fibrolamellar variant, cirrhotic and normal liver.
Schoedel KE; Tyner VZ; Kim TH; Michalopoulos GK; Mars WM
Mod Pathol; 2003 Jan; 16(1):14-21. PubMed ID: 12527708
[TBL] [Abstract][Full Text] [Related]
18. Comparison study of the expressions of myristoylated alanine-rich C kinase substrate in hepatocellular carcinoma, liver cirrhosis, chronic hepatitis, and normal liver.
Masaki T; Tokuda M; Yoshida S; Nakai S; Morishita A; Uchida N; Funaki T; Kita Y; Funakoshi F; Nonomura T; Himoto T; Deguchi A; Kimura Y; Izuishi K; Wakabayashi H; Usuki H; Yoshiji H; Watanabe S; Kurokohchi K; Kuriyama S
Int J Oncol; 2005 Mar; 26(3):661-71. PubMed ID: 15703821
[TBL] [Abstract][Full Text] [Related]
19. Comparative karyometric studies on small pseudolobuli and hepatomas in thioacetamide induced liver cirrhosis.
Bader G; Bader NG; Busch B; Stiller KH
Exp Pathol (Jena); 1975; 10(5-6):241-4. PubMed ID: 183973
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical expression of CD95 (Fas), c-myc and epidermal growth factor receptor in hepatitis C virus infection, cirrhotic liver disease and hepatocellular carcinoma.
El-Bassiouni A; Nosseir M; Zoheiry M; El-Ahwany E; Ghali A; El-Bassiouni N
APMIS; 2006 Jun; 114(6):420-7. PubMed ID: 16856963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
